Strategy
MSTR
Coinbase
COIN
Alphabet-A
GOOGL
Alphabet-C
GOOG
Meritage Homes
MTH
US Stock MarketDetailed Quotes
BBIO BridgeBio Pharma
- 33.540
- +0.530+1.61%
Close Mar 4 16:00 ET
6.38BMarket Cap-11.65P/E (TTM)
33.920High31.690Low2.99MVolume32.720Open33.010Pre Close98.53MTurnover2.25%Turnover RatioLossP/E (Static)190.19MShares39.47052wk High-4.35P/B4.46BFloat Cap21.62052wk Low--Dividend TTM133.09MShs Float73.500Historical High--Div YieldTTM6.76%Amplitude4.980Historical Low32.965Avg Price1Lot Size
BridgeBio Pharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 1.33%-520.73M | -56.49%-195.33M | -24.33%-180.57M | 165.90%74.7M | -52.12%-219.54M | -25.80%-527.72M | -33.86%-124.82M | -7.45%-145.23M | -272.22%-113.35M | 10.16%-144.32M |
| Net income from continuing operations | 16.82%-543.35M | -56.98%-267.39M | 8.49%-164.25M | 52.99%-75.54M | 74.67%-36.16M | -34.79%-653.25M | -21.17%-170.33M | -28.03%-179.49M | -6,179.91%-160.7M | 29.11%-142.73M |
| Operating gains losses | -653.73%-128.68M | 280.19%16.7M | -146,558.06%-45.46M | -6,263.92%-118.37M | 411.88%18.45M | -217.88%-17.07M | -229.83%-9.27M | 98.16%-31K | -373.93%-1.86M | -170.80%-5.92M |
| Depreciation and amortization | -6.45%6.08M | -13.75%1.37M | -6.16%1.54M | -3.85%1.57M | -2.27%1.6M | -4.09%6.49M | -4.52%1.59M | -0.36%1.64M | 3.48%1.64M | -13.32%1.63M |
| Other non cash items | -23.39%17.12M | 72.32%10.66M | -17.39%2.59M | -112.83%-850K | -26.27%4.72M | 125.26%22.34M | -66.24%6.19M | 3.60%3.14M | 106.50%6.62M | 181.28%6.4M |
| Change In working capital | 533.62%32.04M | -41.10%12.95M | -263.39%-2.14M | 1,716.18%246.44M | -608.13%-225.2M | -81.99%5.06M | 87.09%21.98M | 119.08%1.31M | -59.22%13.57M | -215.65%-31.8M |
| -Change in receivables | -119.38%-2.97M | -224.13%-4.24M | -94.71%182K | 10,832.68%234.83M | -3,799.64%-233.74M | 1.05%15.33M | -78.63%3.42M | 190.01%3.44M | 129.53%2.15M | -38.46%6.32M |
| -Change in prepaid assets | -415.10%-13.92M | 310.51%3.63M | -441.83%-11.04M | -168.73%-3.16M | 5.56%-3.35M | -135.22%-2.7M | -147.85%-1.72M | -128.72%-2.04M | 1,363.46%4.6M | -33.31%-3.54M |
| -Change in payables and accrued expense | 640.25%31.42M | -53.80%11.74M | 1,219.56%13.22M | 95.18%17.44M | 64.68%-10.98M | 128.77%4.24M | 554.03%25.4M | 109.63%1M | -64.27%8.94M | -30.85%-31.1M |
| -Change in other current assets | 199.74%1.54M | 165.91%1.97M | -197.09%-1.37M | -3.30%498K | 191.93%444K | -114.09%-1.55M | -441.21%-2.99M | 0.50%1.41M | -34.81%515K | -106.11%-483K |
| -Change in other current liabilities | -22.22%-5.9M | -24.61%-1.44M | -20.36%-1.48M | -16.18%-1.39M | -27.60%-1.6M | 22.67%-4.83M | 18.79%-1.16M | 16.52%-1.23M | 21.92%-1.19M | 31.32%-1.25M |
| -Change in other working capital | 502.26%21.88M | 233.47%1.3M | -29.77%-1.66M | -24.51%-1.79M | 1,474.37%24.02M | -135.63%-5.44M | 42.94%-974K | -490.24%-1.28M | ---1.44M | ---1.75M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 1.33%-520.73M | -56.49%-195.33M | -24.33%-180.57M | 165.90%74.7M | -52.12%-219.54M | -25.80%-527.72M | -33.86%-124.82M | -7.45%-145.23M | -272.22%-113.35M | 10.16%-144.32M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 12.49%60.78M | -4,804.55%-3.24M | 1.44%38.23M | -26.22%3.04M | 85.01%22.75M | -88.08%54.03M | -100.37%-66K | -74.34%37.68M | -97.25%4.12M | -91.13%12.3M |
| Net PPE purchase and sale | 28.56%-933K | 89.20%-47K | 68.21%-137K | 87.38%-54K | -5,691.67%-695K | 72.91%-1.31M | 45.69%-435K | 43.21%-431K | 82.18%-428K | 98.60%-12K |
| Net intangibles purchase and sale | ---7.98M | ---3.19M | ---1.6M | ---2.39M | ---797K | --0 | --0 | --0 | --0 | --0 |
| Net business purchase and sale | 72.17%-140K | ---- | ---- | ---98K | --0 | ---503K | ---- | ---- | --0 | ---503K |
| Net investment purchase and sale | -20.94%44.15M | --0 | 4.95%40M | 22.81%5.58M | -111.22%-1.44M | -83.55%55.84M | -98.03%369K | -74.18%38.11M | -89.57%4.55M | -90.10%12.81M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 12.49%60.78M | -4,804.55%-3.24M | 1.44%38.23M | -26.22%3.04M | 85.01%22.75M | -88.08%54.03M | -100.37%-66K | -74.34%37.68M | -97.25%4.12M | -91.13%12.3M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 65.76%748.46M | 10,578.24%473.93M | -99.77%707K | -365.39%-5.73M | 86.06%279.55M | 3,537.91%451.54M | -170.93%-4.52M | 21,148.44%307.04M | 94.08%-1.23M | 94,005.63%150.25M |
| Net issuance payments of debt | --476.58M | --500M | --0 | --0 | ---23.42M | --0 | --0 | --0 | --0 | --0 |
| Net common stock issuance | -30.64%307.22M | 53.34%-1.4M | -100.48%-1.46M | -1,216.47%-2.24M | 119.16%312.32M | 13,358.83%442.93M | -168.97%-3.01M | 51,040.44%303.61M | 53.55%-170K | 129,649.09%142.5M |
| Proceeds from stock option exercised by employees | -13.27%8.16M | 261.88%2.85M | -66.64%2.17M | 102.52%241K | 44.91%2.9M | 191.75%9.41M | 1,280.70%787K | 218.37%6.5M | 112.50%119K | 87.10%2M |
| Net other financing activities | -5,330.59%-43.5M | -1,095.70%-27.51M | --0 | -216.27%-3.73M | -313.37%-12.25M | -195.70%-801K | -217.58%-2.3M | ---3.06M | ---1.18M | 612.77%5.74M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 65.76%748.46M | 10,578.24%473.93M | -99.77%707K | -365.39%-5.73M | 86.06%279.55M | 3,537.91%451.54M | -170.93%-4.52M | 21,148.44%307.04M | 94.08%-1.23M | 94,005.63%150.25M |
| Net cash flow | ||||||||||
| Beginning cash position | -5.31%394.73M | -22.18%407.88M | 69.27%549.51M | 9.74%477.5M | -5.31%394.73M | 5.18%416.88M | 7.90%524.14M | -31.31%324.64M | 16.28%435.11M | 5.18%416.88M |
| Current changes in cash | 1,402.42%288.51M | 312.79%275.37M | -171.00%-141.63M | 165.19%72.01M | 354.12%82.76M | -207.96%-22.15M | -87.82%-129.41M | 1,418.35%199.5M | -212.20%-110.47M | 182.20%18.23M |
| End cash Position | 73.09%683.24M | 73.09%683.24M | -22.18%407.88M | 69.27%549.51M | 9.74%477.5M | -5.31%394.73M | -5.31%394.73M | 7.90%524.14M | -31.31%324.64M | 16.28%435.11M |
| Free cash flow | -0.11%-529.63M | -58.53%-198.56M | -25.16%-182.3M | 163.50%72.26M | -53.14%-221.03M | -24.24%-529.03M | -33.19%-125.25M | -7.16%-145.66M | -231.19%-113.78M | 10.63%-144.33M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.